Dr. Christopher Paul Myron is a Temple, Texas based male chiropractor who is specialized as General Chiropractor. Active license number of Dr. Christopher Paul Myron as General Chiropractor is 8415 in Texas. Dr. Christopher Paul Myron is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Dr. Christopher Paul Myron speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
D.C.
Gender:
Male
Practice Address:
1901 S 1st St, Temple, Texas, 76504-7451
Phone:
254-743-1217
Fax:
254-743-0028
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1750491981
NPI Enumeration Date:
30 Aug, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Christopher Paul Myron are as mentioned below.
License Number
Specialization
State
Status
8415
Chiropractor
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1901 S 1st St, Temple, Texas
Zip:
76504-7451
Phone Number:
254-743-1217
Fax Number:
254-743-0028
Patients can reach Dr. Christopher Paul Myron at 1901 S 1st St, Temple, Texas or can call to book an appointment on 254-743-1217. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.